Alcami Corporation, a US-based pharmaceutical and biotech contract development and manufacturing organisation, announced on Wednesday that it has completed the acquisition of Masy Systems Inc., a preferred provider of cGMP Biostorage and pharma support services.

Financial terms of the deal were not revealed.

Masy was founded in 1984 by entrepreneurs Laurie and John Masiello and operates three cGMP Biostorage facilities in Massachusetts, all within 1-hour of Boston and Cambridge, with a fourth facility coming online in early 2022. The company said that it offers secure and tightly controlled cGMP temperature storage from -196 degrees C to 70 degrees C, including all ICH stability conditions, for various materials including vaccines, biopharmaceuticals, cell banks, tissues, compounds, and medical devices.

Patrick D. Walsh, Alcami chairman and CEO, said, 'The acquisition of Masy adds complementary service offerings and further reinforces Alcami's ambitious growth and expansion initiatives.'